Quick answer: latest quarter results, by ticker or company name

Reported Q: Q2 2025 Rev YoY: -1.6% EPS YoY: +96.1% Move: -0.04%

Teladoc Health Inc

0LDR.L

$5.01 -0.04%

Exchange LSE Sector Healthcare Industry Medical Equipment Services

Q2 2025

Published: Jul 30, 2025

Company Status Snapshot

Fast view of the latest quarter outcome for 0LDR.L

Reported

Report Date

Jul 30, 2025

Quarter Q2 2025

Revenue

631.90M

YoY: -1.6%

EPS

-0.19

YoY: +96.1%

Market Move

-0.04%

Previous quarter: Q1 2025

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

Revenue of $631.90M down 1.6% year-over-year
EPS of $-0.19 increased by 96.1% from previous year
Gross margin of 69.8%
Net income of -32.66M
"" -

0LDR.L

Company 0LDR.L

Period Q2 2025

Currency USD

Report Type Quarterly Earnings

Generated Feb 10, 2026

Executive Summary

Teladoc Health Inc reported QQ2 2025 revenue of $631.9 million, down 1.64% year-over-year and up 0.40% quarter-over-quarter, reflecting a largely stable top line in a moderated telehealth environment. The company delivered a Gross Profit of $441.363 million on a gross margin of 69.85%, while operating income remained negative at $-54.384 million, showcasing ongoing operating leverage challenges despite a meaningful year-over-year improvement in profitability metrics. Net income came in at $-32.66 million, with basic and diluted earnings per share of $-0.19, underscoring a continued path to sustainable profitability.

Key Performance Indicators

Revenue

Decreasing

631.90M

QoQ: 0.40% | YoY: -1.64%

Gross Profit

Decreasing

441.36M

69.85% margin

QoQ: 2.04% | YoY: -2.87%

Operating Income

Increasing

-54.39M

QoQ: 54.91% | YoY: 93.53%

Net Income

Increasing

-32.66M

QoQ: 64.89% | YoY: 96.10%

EPS

Increasing

-0.19

QoQ: 64.15% | YoY: 96.14%

Revenue Trend

Margin Analysis

Financial Highlights

Revenue: $631.9 million; YoY: -1.64%; QoQ: +0.40%
Gross Profit: $441.363 million; Gross Margin: 69.85%; YoY: -2.87%; QoQ: +2.04%
Operating Income: $-54.385 million; Operating Margin: -8.61%; YoY: +93.53%; QoQ: +54.91%
Net Income: $-32.66 million; Net Margin: -5.17%; YoY: +96.10%; QoQ: +64.89%
EPS (Diluted): $-0.19; YoY: +96.14%; QoQ: +64.15%
EBITDA: $2.675 million; EBITDA Margin: ~0.42%
Cash from Operations: $91.432 million; Free Cash Flow: $90.164 million
Cash at End of Period: $679.621 million; Beginning Cash: $1,193.332 million; Net Change in Cash: -$513.711 million
Total Assets: $2.894 billion; Total Liabilities: $1.4719 billion; Total Stockholders’ Equity: $1.422 billion
Net Debt: $345.591 million; Cash Position Net of Debt: $- (net cash position peers noted)
Current Ratio: 2.67; Quick Ratio: 2.58

Income Statement

Metric	Value	YoY Change	QoQ Change
Revenue	631.90M	-1.64%	0.40%
Gross Profit	441.36M	-2.87%	2.04%
Operating Income	-54.39M	93.53%	54.91%
Net Income	-32.66M	96.10%	64.89%
EPS	-0.19	96.14%	64.15%

Key Financial Ratios

Gross Profit Margin

Excellent

69.80%

Gross profit margin is exceptional, indicating strong pricing power and operational efficiency

Operating Profit Margin

Weak

-0.09%

Operating margin is below industry norms, profitability concerns

Net Profit Margin

Weak

-0.05%

Net profit margin is below industry norms, profitability concerns

Return on Assets

Weak

-0.01%

Return on assets suggests inefficient capital allocation

Return on Equity

Weak

-0.02%

Return on equity suggests inefficient capital allocation

Current Ratio

Strong

2.67

Current ratio indicates excellent liquidity and financial flexibility

Debt to Equity

Elevated

0.73

Debt-to-equity shows significant leverage, monitor debt levels

P/E Ratio

Negative

-11.73x

Negative earnings make P/E ratio not meaningful

Price to Book

Fair Value

1.08x

Price-to-book ratio reasonable for profitable companies

Historical Earnings Comparison

Period	Revenue ($M)	EPS ($)	YoY Growth	Report
Q3 2025	626.44	-0.28	-2.2%	View
Q2 2025	631.90	-0.19	-1.6%	View
Q1 2025	629.37	-0.53	-2.6%	View
Q4 2024	640.49	-0.28	-3.0%	View
Q3 2024	640.51	-0.19	-3.0%	View

0LDR.L

Teladoc Health Inc

Q3 2025 Report

Teladoc Health Inc (0LDR.L) QQ3 2025 Financial Analysis and Investor Outlook...

Read full report

0LDR.L

Teladoc Health Inc

Q1 2025 Report

Teladoc Health Inc (0LDR.L) QQ1 2025 Results: Revenue Stability Amid Margin Pressure and Cash Generation...

Read full report

0LDR.L

Teladoc Health Inc

Q4 2024 Report

Teladoc Health Inc (0LDR.L) QQ4 2024 Results — Telehealth Leader Delivers Positive Cash Flow Amid Revenue Pressure...

Read full report

0LDR.L

Teladoc Health Inc

Q3 2024 Report

Teladoc Health Inc (0LDR.L) QQ3 2024 Results: Modest Revenue Pressure with Positive Cash Generation and a Growth-Focused Outlook...

Read full report

Teladoc Health Inc (0LDR.L) Q2 2025 Earnings Report

Company Status Snapshot

Earnings Highlights

Executive Summary

Key Performance Indicators

Revenue Trend

Margin Analysis

Financial Highlights

Income Statement

Key Financial Ratios

Management Insights Available for Members

Peer Comparison Available for Members

Investment Outlook & SWOT Available for Members

Historical Earnings Comparison

More 0LDR.L Quarterly Reports

0LDR.L

0LDR.L

0LDR.L

0LDR.L

Q2 2025 Reports in Healthcare Sector

0EV1.L

0LHL.L

Related Financial Data

Sector Analysis: Healthcare

0LDR.L Full Profile

0LDR.L Financial Statements

Earnings Calendar